Qubit Pharmaceuticals nominated for "Best start-up" award at Prix Galien USA 2024
19. August 2024 11:00 ET
|
Qubit Pharmaceuticals
Press Release Qubit Pharmaceuticals nominated for "Best start-up" award at Prix Galien USA 2024 - Qubit Pharmaceuticals has been nominated for the 2024 edition of the prestigious Prix Galien USA, in...
Qubit Pharmaceuticals selected as one of the 100 Technology Pioneers 2024 by the World Economic Forum
06. Juni 2024 03:00 ET
|
Qubit Pharmaceuticals
Press release Qubit Pharmaceuticals selected as one of the 100 Technology Pioneers 2024 by the World Economic Forum Qubit Pharmaceuticals joins the prestigious community of 100 disruptive...
High-Performance Computing, simulations and AI: Qubit Pharmaceuticals, Institut Curie and the University of Bordeaux team up to advance the development of novel cancer therapies
30. Januar 2024 02:30 ET
|
Qubit Pharmaceuticals
Press Release High-Performance Computing, simulations and AI: Qubit Pharmaceuticals, Institut Curie and the University of Bordeaux team up to advance the development of novel cancer...
Qubit Pharmaceuticals and Sorbonne University achieve a major scientific breakthrough by simulating quantum calculations at more than 40 qubits on conventional computers
06. Dezember 2023 01:00 ET
|
Qubit Pharmaceuticals
Press release Qubit Pharmaceuticals and Sorbonne University achieve a major scientific breakthrough by simulating quantum calculations at more than 40 qubits on conventional computers Qubit...
Qubit Pharmaceuticals honored to announce the arrival of renowned researcher Dr. Alberto Peruzzo as R&D Lead in Quantum Computing
07. November 2023 17:04 ET
|
Qubit Pharmaceuticals
Press release Qubit Pharmaceuticals honored to announce the arrival of renowned researcher Dr. Alberto Peruzzo as R&D Lead in Quantum Computing Paris (France), November 7, 2023 - Qubit...